Pfizer Inc. (NYSE: PFE) hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE (NASDAQ: BNTX) ...

The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...

European equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.23% to 1,417.34 on the S&P Europe Select ADR Index. For the week, the index is down about 1 ...

While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...

Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUğur ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...

This AI aims to facilitate interdisciplinary collaboration and uncover unexpected connections in scientific research.

In a report released today, Yaron Werber from TD Cowen maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price ...

Google DeepMind and BioNTech are building AI lab assistants to help researchers plan scientific experiments and better ...

Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...